Veranika Razhkova

Veranika Razhkova serves as a Principal at Deerfield Management in New York, specializing on the Therapeutics investment team. In this role, she leads research and analysis for early-stage investments in the therapeutics sector, identifying promising biotechnology and pharmaceutical opportunities. Her expertise centers on evaluating novel drug development platforms, clinical-stage assets, and companies with breakthrough therapeutic innovations.

Before becoming Principal in 2023, she held the position of Analyst at Deerfield Management for nearly five years, gaining deep experience in healthcare-focused venture investing. In addition to her work at Deerfield, she was appointed as a Board Member at Stelexis BioSciences, Inc. in 2024, further demonstrating her commitment to advancing innovation within life sciences and therapeutics.

Veranika holds degrees from Johns Hopkins University, Baruch College, and Kingsborough Community College, reflecting a strong academic foundation in research and finance. Her investment career is distinguished by her contributions to identifying and supporting transformative therapeutic companies, making her a recognized expert in venture and growth investing within the healthcare and biotechnology space.